Fractyl Health (GUTS) Accumulated Depreciation (2023 - 2025)
Fractyl Health's (GUTS) quarterly Accumulated Depreciation came in at $2.7 million in Q4 2025, up 70.78% YoY from $1.6 million in Q4 2024, and up 70.78% on a QoQ basis from $1.6 million in Q4 2024.
Fractyl Health (GUTS) Accumulated Depreciation (2023 - 2025) Analysis & Trends
Fractyl Health (GUTS) has 3 years of Accumulated Depreciation data on file, last reported at $2.7 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 70.78% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 70.78% YoY) and the FY2025 annual result came in at $2.7 million, up 70.78% from the prior year.
- Accumulated Depreciation improved to $2.7 million in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $4.8 million in Q4 2023 to a low of $1.6 million in Q4 2024.
- A 3-year average of $3.0 million and a median of $2.7 million in 2025 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2024 — Accumulated Depreciation tumbled 66.98% — and 2025, when it jumped 70.78%.
- Tracing GUTS's Accumulated Depreciation over 3 years: stood at $4.8 million in 2023, then plunged by 66.98% to $1.6 million in 2024, then jumped by 70.78% to $2.7 million in 2025.
- The last three Accumulated Depreciation figures came in at $2.7 million (Q4 2025), $1.6 million (Q4 2024), and $4.8 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 4.83 Mn |